Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Conen, Patrick E.; Mottaghy, Felix M.

doi:10.1007/s00259-020-04895-8

Eur J Nucl Med Mol Imaging

2020

DOI: 10.1007/s00259-020-04895-8

|View full text |Cite

Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Patrick E. Conen

Felix M. Mottaghy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2022

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 20 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Cited by 3 publications

References 20 publications

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond

Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT

The role of PET in imaging of the tumour microenvironment and response to immunotherapy

Contact Info

Product

Resources

About